Literature DB >> 6749207

Fibrinogen as a risk factor for stroke and myocardial infarction.

L Wilhelmsen, K Svärdsudd, K Korsan-Bengtsen, B Larsson, L Welin, G Tibblin.   

Abstract

To study the possible risk factors for cardiovascular disease, we collected data on plasma levels of coagulation factors, blood pressure, serum cholesterol, and smoking in a random sample of 792 men 54 years of age. During 13.5 years of follow-up, myocardial infarction occurred in 92 men, stroke in 37, and death from causes other than myocardial infarction or stroke in 60. The blood pressure, degree of smoking, serum cholesterol, and fibrinogen level measured at the base-line examination proved to be significant risk factors for infarction by univariate analyses during follow-up, and blood pressure and fibrinogen were risk factors for stroke. Fibrinogen and smoking were strongly related to each other. The relation between fibrinogen and infarction, and between fibrinogen and stroke, became weaker when blood pressure, serum cholesterol, and smoking habits were taken into account, but was still significant for stroke. Although causality cannot be inferred from these data, it is possible that the fibrinogen level plays an important part in the development of stroke and myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6749207     DOI: 10.1056/NEJM198408233110804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  184 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 3.  [Non-lipid effects of statins: myth or fact?].

Authors:  Eleonora Urbauer; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2003

Review 4.  Fibrinogen/fibrin in atherogenesis.

Authors:  E B Smith; W D Thompson; L Crosbie; C M Stirk
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 5.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

6.  Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls.

Authors:  M L Knapp; M D Feher; H Carey; P D Mayne
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

7.  Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey.

Authors:  D MacAuley; E E McCrum; G Stott; A E Evans; B McRoberts; C A Boreham; K Sweeney; T R Trinick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 8.  Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.

Authors:  S U Shah; A White; S White; W A Littler
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

9.  Acute cardiovascular effects of firefighting and active cooling during rehabilitation.

Authors:  Jefferey L Burgess; Michael D Duncan; Chengcheng Hu; Sally R Littau; Delayne Caseman; Margaret Kurzius-Spencer; Grace Davis-Gorman; Paul F McDonagh
Journal:  J Occup Environ Med       Date:  2012-11       Impact factor: 2.162

10.  Hyperfibrinogenemia and functional outcome from acute ischemic stroke.

Authors:  Gregory J del Zoppo; David E Levy; Warren W Wasiewski; Arthur M Pancioli; Andrew M Demchuk; James Trammel; Bart M Demaerschalk; Markku Kaste; Gregory W Albers; Eric B Ringelstein
Journal:  Stroke       Date:  2009-03-19       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.